Anlon Healthcare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -10.12% vs 120.03% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is 81.61% vs 6.10% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Anlon Healthcare With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

35.58

93.88

-58.30

-62.10%

Other Operating Income

0.00

Total Operating income

35.58

93.88

-58.30

-62.10%

Raw Material Cost

26.10

51.05

-24.95

-48.87%

Purchase of Finished goods

0.00

1.23

-1.23

-100.00%

(Increase) / Decrease In Stocks

-6.03

0.47

-6.50

-1,382.98%

Employee Cost

1.71

8.41

-6.70

-79.67%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

1.46

15.05

-13.59

-90.30%

Total Expenditure (Excl Depreciation)

23.24

76.21

-52.97

-69.51%

Operating Profit (PBDIT) excl Other Income

12.34

17.67

-5.33

-30.16%

Other Income

0.20

0.32

-0.12

-37.50%

Operating Profit (PBDIT)

12.54

17.99

-5.45

-30.29%

Interest

1.58

1.16

0.42

36.21%

Exceptional Items

0.00

Gross Profit (PBDT)

10.96

16.83

-5.87

-34.88%

Depreciation

0.35

1.25

-0.90

-72.00%

Profit Before Tax

10.61

15.58

-4.97

-31.90%

Tax

5.46

3.45

2.01

58.26%

Provisions and contingencies

0.00

Profit After Tax

5.15

12.13

-6.98

-57.54%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

5.15

12.13

-6.98

-57.54%

Equity Capital

53.15

48.29

4.86

10.06%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

0.97

2.51

-1.54

-61.35%

Diluted Earnings per share

1.13

2.51

-1.38

-54.98%

Operating Profit Margin (Excl OI)

34.68%

18.82%

0.00

15.86%

Gross Profit Margin

30.80%

17.93%

0.00

12.87%

PAT Margin

14.47%

12.92%

0.00

1.55%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 35.58 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 280.13%

Quarterly - Standalone Net Profit

Standalone Net Profit 5.15 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 306.83%

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 12.34 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -10.12% vs 120.03% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 2,027.59%

Quarterly - Interest

Interest 1.58 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 81.61% vs 6.10% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 77.53%

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 34.68%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024